CYP2E1 and metabolic dysfunction-associated steatotic liver disease: In contrast, other studies of the diseased liver samples such as hepatocellular carcinoma (HCC), non-alcoholic fatty liver disease (NAFLD), and alcoholic liver disease (ALD) report broad epigenetic alterations but do not provide details on CYP2E1-specific methylation changes [29,30,31].